Quantinuum’s (QNT) “Buy” Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities reiterated their buy rating on shares of Quantinuum (NASDAQ:QNT) in a research note published on Thursday,Benzinga reports. Rosenblatt Securities currently has a $155.00 price target on the stock.

Other research analysts have also issued reports about the company. UBS Group started coverage on Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $93.00 price target for the company. Craig Hallum started coverage on Quantinuum in a research note on Monday, June 29th. They set a “buy” rating and a $100.00 price objective for the company. Mizuho began coverage on Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $90.00 price objective on the stock. Evercore began coverage on Quantinuum in a research note on Monday, June 29th. They issued an “outperform” rating and a $98.00 target price on the stock. Finally, Sanford C. Bernstein reiterated a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Thirteen investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $94.23.

Quantinuum Stock Up 1.7%

Shares of NASDAQ:QNT opened at $36.50 on Thursday. The company has a market capitalization of $9.61 billion and a P/E ratio of -130.36. Quantinuum has a 52 week low of $33.02 and a 52 week high of $86.79. The business has a 50 day simple moving average of $47.51.

Quantinuum (NASDAQ:QNT) last posted its earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. As a group, equities analysts anticipate that Quantinuum will post -4.76 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Quantinuum

Institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP purchased a new stake in shares of Quantinuum during the second quarter worth about $92,418,000. HBK Investments L P acquired a new position in shares of Quantinuum during the second quarter valued at about $14,669,000. BlueCrest Capital Management Ltd purchased a new position in shares of Quantinuum in the 2nd quarter valued at approximately $14,304,000. McGuire Investment Group LLC raised its position in shares of Quantinuum by 1,892.4% in the 3rd quarter. McGuire Investment Group LLC now owns 57,360 shares of the company’s stock valued at $2,757,000 after purchasing an additional 54,481 shares during the last quarter. Finally, Readystate Asset Management LP purchased a new position in shares of Quantinuum in the 2nd quarter valued at approximately $4,111,000.

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.